Literature DB >> 20624155

Epigenetic modulation at the CCR2 gene correlates with the maintenance of behavioral sensitization to methamphetamine.

Daigo Ikegami1, Minoru Narita, Satoshi Imai, Kazuhiko Miyashita, Rie Tamura, Michiko Narita, Shigemi Takagi, Akiko Yokomizo, Hideyuki Takeshima, Takayuki Ando, Katsuhide Igarashi, Jun Kanno, Naoko Kuzumaki, Toshikazu Ushijima, Tsutomu Suzuki.   

Abstract

The intermittent administration of methamphetamine produces behavioral sensitization to methamphetamine. In the limbic forebrain, mainly including the nucleus accumbens, of mice that had been intermittently treated with methamphetamine, we found a significant increase in mRNA of a chemokine, CCR2. This increase was accompanied by a significant increase in histone H3 lysine 4 (H3K4) trimethylation at its promoter. Interestingly, the maintenance of sensitization to methamphetamine-induced hyperlocomotion was significantly decreased in CCR2 knockout mice. These findings suggest that increased CCR2 associated with epigenetic modification after the intermittent administration of methamphetamine may be associated with the maintenance of sensitization to methamphetamine-induced hyperlocomotion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624155     DOI: 10.1111/j.1369-1600.2010.00219.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  13 in total

1.  Methamphetamine alters DNMT and HDAC activity in the posterior dorsal medial amygdala in an ovarian steroid-dependent manner.

Authors:  Sarah A Rudzinskas; Jessica A Mong
Journal:  Neurosci Lett       Date:  2018-06-23       Impact factor: 3.046

2.  Implication of CCR2 chemokine receptor in cocaine-induced sensitization.

Authors:  Jean Marc Trocello; William Rostene; Stephane Melik-Parsadaniantz; David Godefroy; Emmanuel Roze; Patrick Kitabgi; William A Kuziel; Sylvie Chalon; Jocelyne Caboche; Emmanuelle Apartis
Journal:  J Mol Neurosci       Date:  2011-03-22       Impact factor: 3.444

Review 3.  Epigenetic Effects of Addictive Drugs in the Nucleus Accumbens.

Authors:  Ethan M Anderson; Makoto Taniguchi
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

4.  The Epigenetic Mechanisms of Amphetamine.

Authors:  Talus J McCowan; Archana Dhasarathy; Lucia Carvelli
Journal:  J Addict Prev       Date:  2015-02-09

Review 5.  Epigenetics and addiction.

Authors:  J L Cadet; M T McCoy; S Jayanthi
Journal:  Clin Pharmacol Ther       Date:  2016-02-22       Impact factor: 6.875

Review 6.  Chemokines, cytokines and substance use disorders.

Authors:  Olivia C Ahearn; Mia N Watson; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2021-01-08       Impact factor: 4.492

Review 7.  Epigenetic Landscape of Methamphetamine Use Disorder.

Authors:  Jean Lud Cadet; Subramaniam Jayanthi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 8.  Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.

Authors:  Arthur Godino; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

9.  Methamphetamine Induces TET1- and TET3-Dependent DNA Hydroxymethylation of Crh and Avp Genes in the Rat Nucleus Accumbens.

Authors:  Subramaniam Jayanthi; Betina Gonzalez; Michael T McCoy; Bruce Ladenheim; Veronica Bisagno; Jean Lud Cadet
Journal:  Mol Neurobiol       Date:  2017-08-25       Impact factor: 5.590

10.  The Effects of Maternal Separation on Adult Methamphetamine Self-Administration, Extinction, Reinstatement, and MeCP2 Immunoreactivity in the Nucleus Accumbens.

Authors:  Candace R Lewis; Kelsey Staudinger; Lena Scheck; M Foster Olive
Journal:  Front Psychiatry       Date:  2013-06-17       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.